Beijing Friendship Hospital, Capital Medical University.No. 95, Yongan Road, Xicheng District, Beijing, 100050, China
Beijing, Beijing Municipality, 100050, China
NCT Number: NCT07635355
This study aims to address the lack of intelligent governance tools in clinical data management to promote efficient governance and secure sharing of real-world health data. To achieve this, a self-adaptive, automated governance intelligent agent will be developed based on a High-Order Programming (HOP) architecture, integrating Large Language Models (LLMs) and deep learning techniques. The agent will continuously monitor and correct data quality issues in real time, improving data accuracy and usability.
In parallel, the project will establish a trusted data-sharing framework by integrating AI Confidential Computing (AICC) with Trusted Data Matrix (TDM) technologies. This framework will enable secure, real-time cross-institutional data exchange and collaborative computation while protecting sensitive information.
Overall, the study aims to transform fragmented clinical data into high-quality, standardized, and securely accessible resources, thereby facilitating the circulation of data value and advancing collaborative medical research.
Trial opening soon.
Get NotifiedAll sexes
Observational
Beijing, Beijing Municipality, 100050, China
This multicenter, observational cohort study aims to integrate longitudinal health data from China, including routine health examinations, electronic medical records, and disease registries. The platform is designed to address key data challenges in the medical domain, particularly in chronic diseases and suboptimal health status. It is driven by two primary objectives:
Overall Objective The platform aims to transform heterogeneous clinical data into standardized, high-quality, and securely accessible resources, thereby enabling efficient data utilization and promoting the value circulation of medical data for real-world evidence research.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is an observational study. No intervention will be applied.
Time frame: 2026.5.30 to 2028.12.31
Using a manually curated gold-standard dataset, the effectiveness of the intelligent agent in improving data accuracy will be evaluated by measuring the proportion of data values that correctly match the gold-standard reference after automated data governance. The accuracy rate will be calculated as the percentage of correctly recorded or corrected data elements among all evaluated data elements. Values range from 0% to 100%, with higher values indicating better data accuracy.
Time frame: 2026.5.30 to 2028.12.31
Using a manually curated gold-standard dataset, the effectiveness of the intelligent agent in improving data completeness will be evaluated by measuring the proportion of required data fields that are complete after automated data governance. The completeness rate will be calculated as the percentage of non-missing required data elements among all required data elements. Values range from 0% to 100%, with higher values indicating better data completeness.
Time frame: 2026.5.30 to 2028.12.31
Using a manually curated gold-standard dataset, the effectiveness of the intelligent agent in resolving identified data quality issues will be evaluated by measuring correction accuracy. Correction accuracy will be calculated as the percentage of identified data quality issues (e.g., missing values, format inconsistencies, and logical conflicts) that are correctly resolved after automated data governance, compared with the gold-standard reference dataset. Values range from 0% to 100%, with higher values indicating better correction performance.
Time frame: 2026.5.30 to 2028.12.31
Using a manually curated gold-standard dataset, the effectiveness of the intelligent agent in standardizing data will be evaluated by measuring the proportion of data elements that conform to predefined data standards, terminologies, and formatting rules after automated data governance. The data standardization rate will be calculated as the percentage of evaluated data elements that meet standardized data specifications among all assessed data elements. Values range from 0% to 100%, with higher values indicating better data standardization.
Time frame: 2026.5.30 to 2028.12.31
Using datasets derived from participating institutions, the effectiveness of the intelligent agent in improving cross-institutional data usability will be evaluated by measuring the proportion of governed datasets that can be successfully integrated, interpreted, and used across different institutions according to predefined interoperability and usability criteria after automated data governance. Cross-institutional data usability will be calculated as the percentage of datasets meeting prespecified usability criteria among all evaluated datasets. Values range from 0% to 100%, with higher values indicating better cross-institutional usability.
Contact information is provided by the study sponsor or research team.
Hao Wang, PhD
CONTACT
+86 18301250922 ext. +86 1063139363
Yuanyuan Kong, PhD
CONTACT
+86 15810026760 ext. +86 1063139362
Beijing Friendship Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07672704
Balance Disorders, Chronic Disease
Alexandria, Egypt
View Trial DetailsNCT07645911
Behavior, Chronic Disease
View Trial DetailsNCT06996899
Chronic Disease, Chronic Diseases
View Trial DetailsNCT07601308
Behavior, Cardiovascular Diseases
Alexandria, Alexandria Governorate, Egypt
View Trial Details